← FDA Drug Approvals (Drugs@FDA)

RELAFEN

NDA · New Drug Application · Sponsor: SMITHKLINE BEECHAM · Approved 1991-12-24

Drug application

FDA Application #

NDA019583

Application type

New Drug Application

Brand name

RELAFEN

Generic name

Nabumetone

Active ingredients

NABUMETONE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

SMITHKLINE BEECHAM

First approval

1991-12-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown